Avances en la base genética de la obesidad

Medicina Clinica

Volumn 112, Issue 17, 1999, Pages 664-668

  Cuatrecasas, Guillem ^a,b   Formiguera, Xavier ^a   Foz, Márius ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL; CHROMOSOME ABERRATION; CHROMOSOME DISORDER; DIABETES MELLITUS; GENETICS; HUMAN; MOUSE; OBESITY; RAT; REVIEW;

AMINO ACIDS; ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DIABETES MELLITUS; HUMANS; MICE; NEUROPEPTIDE Y; OBESITY; RATS; RNA, MESSENGER;

EID: 0033562001     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Rosenbaum M, Leibel RL. Pathophysiology of childhood obesity. Adv Pediatr 1988; 35: 73-137.
2. Stunkard AJ, Sorensen TIA, Hanis C, Teasdale TW, Chakraborty R, Schull WJ et al. An adoption study of human obesidy. N Engl J Med 1986; 314: 193-198.
3. Bouchard C, Tremblay A, Nadeau A, Despres JP, Theriault G, Boulay MR et al. Genetic effect in resting and exercise metabolic rates. Metabolism 1989; 38: 364-370.
4. Coleman DL, Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol 1969; 217: 1.298-1.304.
5. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature (Lond) 1994; 372: 425-432.
6. Bahary N, Leibel RL, Joseph L, Friedman JM. Molecular mapping of the mouse db mutation. Proc Natl Acad Sci USA 1990; 87; 8.642-8.646.
7. Ricquier D, Casteilla L, Boulllaud F. Molecular studies of the uncoupling protein FASEB 1991; 5: 2.237-2.242.
8. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
9. Halaas JS, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-546.
10. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse of protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
11. Maffei M, Stoffel M, Barone M, Moon B, Dammerman M, Ravussin E et al. Absence of mutations in the human ob gene in obese/diabetic subjects. Diabetes 1996; 45: 679-682.
12. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ et al. Congenital leptin deficiency is associated with severe-early onset obesity in humans. Nature (Lond) 1997; 387: 903-908.
13. Lönquist F, Arner P, Nordfors L, Schalling M. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1995; 1: 949-950.
14. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292-295.
15. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Chem 1996; 942-946.
16. Clément K, Garner C, Hager J, Philippi A, LeDuc C, Carey A et al. Indication for linkage of the human ob gene region with extreme obesity. Diabetes 1996; 45: 687-690.
17. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1.455-1.462.
18. Hwang CS, Mandrup S, McDougal OA, Geiman DE, Lane MD. Transcriptional activation of the mouse obese (ob) gene by CAAT/enhancer binding protein α. Proc Natl Acad Sci USA 1996; 93: 873-877.
19. Nolan JJ, Olefsky MJ, Nyce MR, Considine RV, Caro JF. Effect of troglitazone on leptin production. Diabetes 1996; 45: 1.276-1.278.
20. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin: a relationship leading to the clues to the understanding of obesity. Diabetes 1995; 44: 1467-1.470.
21. Dagogo-Jack S, Fanelli C, Paramore D, Brother J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45: 695-698.
22. Kolacsinsky JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R et al. Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
23. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and nondiabetic Mexican-Americans Diabetes 1996; 45: 822-824.
24. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S et al. Nocturnal rise of leptin in lean, obese and non-insulin dependent diabetic patients. J Clin Invest 1996; 97: 1.344-1.347.
25. Cumin F, Baum HP, Levens N. Kidney is the major site of plasma leptin clearance. Int J Obes 1996; 4 (Supl 1): 38.
26. Sanchis D, Balada F, Grasa MM, Virgili J, Peinado J, Montserrat C et al. Oleyl-estrone induces the loss of body fat in rats. Int J Obes 1996; 20: 588-594.
27. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996; 84: 491-495.
28. Tartaglia LA, Dembski M, Tepper RI, Weng X, Deng N, Culpepper J et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83: 1.263-1.271.
29. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature (Lond) 1996; 379: 632-634.
30. Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D et al. A mutation in the human receptor gene causes obesity and pituitary disfunction. Nature (Lond) 1998; 392: 398-401.
31. Stanley BG. Neuropeptide Y in multiple hypothalamic sites control eating behavior, endocrine, and autonomic systems for energy balance. The biology of neuropeptide Y and related peptides. Nueva Jersey: Humana Totowa, 1993; 457-509.
32. Vettor R, Zarjevski N, Cusin Y, Rohner-Jeanrenaud F, Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular NPY administration to normal rats. Diabetologia 1994; 37: 1.202-1.208.
33. Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y Gene expression in ob/ob mice. Diabetes 1996; 45: 531-535.
34. Stephens TW, Basinski M, Bristow PK, Bue-Valeskey JM, Burgett SG, Craft L et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature (Lond) 1995; 377: 530-522.
35. Dotsh J, Adelmann J, Englaro P, Dotsch A, Hanze J, Blum WF et al. Relation of leptin and NPY in human blood and cerebrospinal fluid. J Neural Sci 1997; 151: 185-188.
36. Trayhurn P. Thomas MEA, Duncan JS, Rayner DV. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese mice. FEBS Lett 1995; 368: 488-490.
37. Llopis MA, Granada ML, Cuatrecasas G, Formiguera X, Sánchez-Planell L, Alastrué A et al. GH-binding protein (GHBP) directly depends on serum leptin levels in adults with different nutritional status. J Clin Endocrinol Metab 1998; 83: 2.006-2.011.
38. Kiefer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic p-cell. Biochem Biophys Res Commun 1996; 224: 522-527.
39. Friedman JE, Ishizuka T, Liu S, Farrell CJ, Bedol D, Koletsky RJ et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol 1997; 273: 1.014-1.023.
40. Cuatrecasas G, Granada ML, Formiguera X, Rull M, Alastrué A, Remesar X et al. Increased leptin production in vivo and insulin cleavage by the epiploic adipose tissue of morbid obese patients. Clin Endocrinol 1998; 48: 181-185.
41. Remesar X, Rafecas I, Fernández-López JA, Alemany M. Is leptin and insulin counter-regulatory hormone? FEBS Lett 1997; 402: 9-11.
42. Fernández-Real JM, Gutiérrez C, Ricart W, Casamitjana R, Fernández-Castañer M, Vendrell J et al. The TNFα gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat and incresed serum leptin levels. Diabetes 1997; 46: 1.468-1.472.
43. Cassard-Doulcier AM, Gely C, Fox N, Schrementi J, Raimbault S, Klaus S et al. Tissue-specific and β-adrenergic regulation of the mitochondrial uncoupling protein gene: control by cis-acting elements in the 5′-flanking region. Mol Endocrinol 1993; 7: 497-506.
44. Ricquier D, Mory G. Factors affecting brown adipose tissue in animals and man. Clin Endocrinol 1984; 13: 501-520.
45. Himms-Hagen J. Brown adipose tissue metabolism. En: Björntorp P, Brodoff BN, editores. Obesity. Filadelfe JB Lippincott, 1992; 117-129.
46. Fleury C, Neverova M, Collins M, Raimbault S, Champigny O, Levi-Meyruei S et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997; 15: 269-272.
47. Enerbäck S, Jacobsson A, Simpson EM, Guerra C, Yamashita H, Harper ME et al. Mice lacking mitochondrial uncoupling proteinare cold-sensitive but not obese. Nature (Lond) 1997; 387: 90-94.
48. Zhou YT, Shimabukuro M, Koyama K, Lee V, Wang MY, Trieu F et al. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci USA 1997; 94: 6.386-6.390.
49. Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J et al. Uncoupling protein-3: a new member of the mithochondrial carrier family with tissue-specific expression. FEBS Lett 1997; 408: 39-42.
50. Björntorp P. Regional obesity. En: Björntorp P, Brodoff BN, editores. Ogesity. Filadelfia: JB Lippincott, 1992; 579-586.
51. Yen TT. Obesity, diabetes and neoplasia in yellow Avy/-mice: ectopic expression of the Agouti gene. FASEB 1994; 8: 479-486.
52. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase gene. Nat Genet 1997; 16: 303-306.